MedPath

Weight Fluctuation After Breast Cancer Treatment

Completed
Conditions
Breast Cancer
Weight Gain
Interventions
Procedure: Fasting blood sample.
Registration Number
NCT00991653
Lead Sponsor
The Royal Bournemouth Hospital
Brief Summary

This study aims to identify and quantify the factors associated with excess weight gain following treatment for breast cancer. It is believed that breast cancer patients gain more than 4% of their weight at diagnosis which is likely accompanied by an increase in body fat and waist circumference. It is further thought that this excess weight and increase in body fat and waist circumference are associated to tumour characteristics, chemotherapy, menopause status at diagnosis and the presence of genes related to obesity. It is also thought that women treated with chemotherapy have higher levels of glucose and insulin.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
250
Inclusion Criteria
  • Females 18 years of age or older.
  • Diagnosed with breast cancer between 1/1/2003 and 31/12/2007.
  • Able to understand and willing to sign informed consent.
Exclusion Criteria
  • Known diagnosis of previous breast/other cancer (other than completely resected non-melanoma skin cancer or successfully treated in situ cancer of the cervix.
  • Known diagnosis of inflammatory bowel disease or malabsorption syndrome.
  • Known diagnosis of endocrine problems associated with the development of obesity (cushings syndrome, hypo/hyperthyroid, thyroiditis)
  • Treatment for psychiatric disorders.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Breast cancerFasting blood sample.Diagnosed with breast cancer 1/1/2003 - 31/12/2007.
Primary Outcome Measures
NameTimeMethod
To provide evidence of the relationship between weight gain following diagnosis of breast cancer and tumour characteristics, chemotherapy, menopause status at diagnosis and the presence of genes related to obesity.12-18 months.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath